Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
The participant is ≥ 18 years of age.
The participant has signed an approved consent for this study (living patients only)
None
Patients with ILD, RLD and subjects at risk for ILD
Cohort
Prospective
Not listed
Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research.
Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD.
Correlate biological samples with individual longitudinal clinical data.
Provide biological samples to researchers performing studies in ILD and RLD.
Click on the lead sponsor to view all of their trials.
